Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of H001 capsule for prevention of venous thromboembolism after total knee arthroplasty
CTR20244921Phase 2Completed
- Sponsor
- Livzon Pharmaceutical Group Inc.
- Start
- Jan 2025
- Countries
- 1
01
Overview
A Phase 2 trial of H001 in venous thromboembolism (VTE), sponsored by Livzon Pharmaceutical Group Inc.. Started Jan 2025; status: completed.
02
Drugs
H001
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on CTR20244921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244921.